Day: November 30, 2022

Eisai And Biogen’s Alzheimer’s Drug Slows Down Cognitive Decline, But Has Side Effects

According to detailed data presented on Tuesday, an experimental Alzheimer’s drug from Eisai and Biogen slowed cognitive decline in a closely watched trial but may carry a risk of serious side effects for certain patients. The drug, lecanemab, was linked… Read More ›